Singapore approves Pfizer-BioNTech COVID-19 vaccine

Singapore’s Health Sciences Authority (HSA) has approved the COVID-19 vaccine developed by United States pharmaceutical giant Pfizer and German firm BioNTech, with the first shipment due to arrive by the end of December, announced Prime Minister Lee Hsien Loong on Monday (Dec 14). 

This makes Singapore one of the first countries to obtain this vaccine, he said.

Both scientific evidence and clinical trial data for the Pfizer-BioNTech vaccine were studied by HSA. 

VACCINATIONS FOR ENTIRE ADULT POPULATION

The Ministry of Health has established a committee of doctors and experts to recommend a vaccination strategy and they have proposed that our entire adult population should be vaccinated, but to make vaccinations voluntary.

Priority will be given to those at greatest risk, such as frontline and healthcare workers, and the elderly and vulnerable.

The committee also proposes to progressively vaccinate the rest of the population and to cover everyone who wants a vaccination by the end of next year.

The Government has accepted the committee’s recommendations.

SOURCE: CNA